Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

This study has been withdrawn prior to recruitment.

( Study withdrawn for financial problems. We didnwt get a grant we needed for purchesing the medication for the study. )

First Received: May 23, 2006 Last Updated: June 26, 2008 History of Changes

Sponsor:	The Baruch Padeh Medical Center, Poriya
Information provided by:	The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier:	NCT00329316

Purpose

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

Condition	Intervention
Pregnancy Premature Birth	Drug: Crinone Gel 8%

Study Type:	Interventional
Study Design:	Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study

Resource links provided by NLM:

Drug Information available for: Progesterone

Eligibility

Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00329316

Sponsors and Collaborators

The Baruch Padeh Medical Center, Poriya

Investigators

Study Chair:	Yuri Perlitz, MD	The Baruch Padeh Medical Center, Poriya
Principal Investigator:	Mosheh Ben Ami, Prof.	Head of Obs/Gyn ,The Baruch Padeh Medical center, Poriya

More Information

No publications provided

Study ID Numbers:	PTL Progesterone Perlitz.CTIL
Study First Received:	May 23, 2006
Last Updated:	June 26, 2008
ClinicalTrials.gov Identifier:	NCT00329316 History of Changes
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by The Baruch Padeh Medical Center, Poriya:

Pre-term labor
progesterone

Additional relevant MeSH terms:

Pregnancy Complications
Progesterone
Progestins
Obstetric Labor, Premature
Physiological Effects of Drugs

Hormones, Hormone Substitutes, and Hormone Antagonists
Obstetric Labor Complications
Hormones
Pharmacologic Actions
Premature Birth

ClinicalTrials.gov processed this record on November 30, 2009